Want to improve the page's content? Try to propose a change.
A federal public health agency does not diagnose or treat prostate cancer.
What the CDC does instead is a useful illustration of how population-level
health work differs from medicine, and its prostate cancer activities fall
into four kinds.
1. Fixing the data
Improving what cancer registries record about prostate cancer —
specifically the grade and stage at diagnosis, **trends in the care
given**, and the race and ethnicity of the men diagnosed.
This is the least visible item and arguably the most important. Whether
screening helps is a question nobody can answer without knowing which cancers
were caught at which stage, in whom, and what was then done about them. A
registry that records "prostate cancer" and little else cannot settle it.
2. Helping men decide
Developing communication and decision-aid tools — including *Habla con
Nathan* ("Talk with Nathan") — because prostate cancer screening is, uniquely
among common cancer screenings, a genuine decision rather than a
recommendation. The benefits and the harms are real and they trade off against
each other, so the useful intervention is one that helps a man weigh them.
3. Finding out what people actually know
**Sponsoring research into what men and their doctors understand about
prostate cancer screening.** Not what the guidance says — what the
conversation in the room actually contains.
4. Coordination
- Producing research and materials that communicate about screening and
treatment - Monitoring the prostate cancer activities written into local
comprehensive cancer control plans - Taking part in conferences, workshops and seminars to build
collaboration with partners
None of that shows up at a patient's appointment, and all of it shapes what
happens there.
Source: Centers for Disease Control and Prevention.
Licence: CC0 1.0 (public domain) · Adapted from www.cdc.gov
1
0
0
0
Comments
Read next
